Bismuth, rabeprazole, amoxicillin, and doxycycline as first‐line Helicobacter pylori therapy in clinical practice: A pilot study

阿莫西林 医学 幽门螺杆菌 养生 内科学 雷贝拉唑 胃肠病学 不利影响 尿素呼气试验 强力霉素 埃索美拉唑 抗生素 幽门螺杆菌感染 生物 微生物学
作者
Lei Gu,Shenglan Li,Ying Zi He,Yi Chen,Yanzhi Jiang,Yu Peng,Xiaowei Liu,Huixiang Yang
出处
期刊:Helicobacter [Wiley]
卷期号:24 (4): e12594-e12594 被引量:31
标识
DOI:10.1111/hel.12594
摘要

Abstract Background Bismuth‐containing quadruple therapy (BQT) is a recommended alternative first‐line therapy for Helicobacter pylori (H. pylori) infection. We aim to evaluate the efficacy and safety of a new BQT with amoxicillin and doxycycline as a first‐line treatment for H. pylori infection in clinical practice. Methods An open, prospective pilot clinical study including H. pylori‐positive outpatients who had never received eradication treatment was carried out. An RADB regimen (10 mg rabeprazole, 1000 mg amoxicillin, 100 mg doxycycline, and 220 mg colloidal bismuth tartrate, all given bid for 14 days) was prescribed by gastroenterologists. H. pylori eradication was confirmed by a 13C‐urea breath test performed at least 6 weeks after the end of treatment. Regimen efficacy was evaluated by per‐protocol (PP) and intention‐to‐treat (ITT) analyses. Results One hundred eighteen patients were included in the study. The eradication rate of RADB was 93.8% (105/112; 95% CI 89.2%‐98.3%) in PP analysis and 89.8% (106/118; 95% CI 84.3%‐95.4%) in ITT analysis. The patient compliance rate was 97.5% (115/118). The adverse event rate was 6.8% (8/118). Adverse events included asthenia, loss of appetite, dry mouth, heartburn, diarrhea, and abdominal pain. All adverse events disappeared after completion of therapy. Conclusion Our results suggest that 14‐day BQT with amoxicillin and doxycycline can be an effective and safe eradication regimen for first‐line therapy against H. pylori infection in clinical practice.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Ethereal发布了新的文献求助10
刚刚
1秒前
2秒前
3秒前
3秒前
3秒前
Jasper的应助被benhzh采纳,获得10
4秒前
菜不透完成签到,获得积分10
4秒前
蓝月发布了新的文献求助10
6秒前
JIMS发布了新的文献求助10
6秒前
柠檬不萌完成签到 ,获得积分10
7秒前
7秒前
7秒前
Lucas的应助被科研通管家采纳,获得20
9秒前
9秒前
NexusExplorer的应助被科研通管家采纳,获得10
9秒前
充电宝的应助被科研通管家采纳,获得10
9秒前
9秒前
9秒前
ZRJ完成签到 ,获得积分10
10秒前
Hello的应助被科研通管家采纳,获得10
10秒前
隐形曼青的应助被科研通管家采纳,获得10
10秒前
10秒前
10秒前
wanci的应助被青山采纳,获得10
10秒前
清新的宛丝完成签到,获得积分10
10秒前
10秒前
丘比特的应助被penta采纳,获得10
10秒前
benhzh完成签到,获得积分10
10秒前
假发君发布了新的文献求助10
11秒前
烟花的应助被瓦伦泰采纳,获得10
11秒前
13秒前
14秒前
14秒前
所所的应助被barrychow采纳,获得10
14秒前
15秒前
15秒前
15秒前
珊珊完成签到 ,获得积分10
16秒前
Akim的应助被学术猪八戒采纳,获得30
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158056
求助须知:如何正确求助?哪些是违规求助? 9553944
关于积分的说明 21716733
捐赠科研通 7747388
什么是DOI,文献DOI怎么找? 3426934
关于科研通互助平台的介绍 2551676
邀请新用户注册赠送积分活动 2471038